Congressional Forum on Biotech/Device Jobs Focuses on FDA

Published: Apr 22, 2011 -- April 22, 2011 -- Overly cautious government regulators, threats to basic science research funding and burdensome taxes are holding back job creation by drug and medical device companies and slowing the delivery of innovative new therapies to patients, biotechnology industry experts told federal lawmakers Thursday during a hearing in San Diego.

Back to news